Life Sciences

Genomenon Offers Free Edition Of Mastermind Search Engine

ANN ARBOR - Genomenon has announced that it will begin offering a free edition of the Mastermind Genomic Search Engine to clinical, research and academic institutions to advance genomic analysis and DNA data interpretation. Genomenon is making Mastermind freely available to promote more rapid advances in genome analysis and DNA sequencing interpretation. Mastermind is a

By |2017-10-22T16:38:48-04:00October 22nd, 2017|Life Sciences|

GVSU Premed Students Get Admission Assurance To CMU Medical College

MOUNT PLEASANT - A new cooperative agreement will grant Grand Valley State University premedical students early assurance of admission to the Central Michigan University College of Medicine through the Early Assurance Program. The agreement — signed by GVSU President Dr. Thomas Hass and CMU President Dr. George Ross on October 19 in a formal ceremony

By |2017-10-22T15:21:21-04:00October 22nd, 2017|Life Sciences|

U-M Report: Injured Neuron Pathways May Contribute To Alzheimer’s, ALS

ANN ARBOR - An injury pathway in the neurons of fruit flies may cause the loss of synapses in diseases such as Alzheimer's and ALS, according to University of Michigan researchers. This pathway, called DLK, has received recent attention as a candidate drug target because it contributes to the deterioration of damaged neurons. The new

By |2017-10-04T12:25:54-04:00October 4th, 2017|Life Sciences|

U-M launches Precision Health Research Initiative

ANN ARBOR - The University of Michigan has launched a new initiative to harness campus-wide research aimed at finding personalized solutions to improve the health and wellness of individuals and communities. Precision Health at the University of Michigan will bring together researchers from across the university to coordinate this new and exciting type of research.

By |2017-10-04T10:01:54-04:00October 4th, 2017|Featured, Life Sciences|

As Retirement Age Creeps Up, Health Of Those Close To Retirement Getting Worse

ANN ARBOR - Ten years from now, Americans born in 1960 will be able to start collecting their full Social Security retirement check, at the age of 67. That's two years later than their parents, because of a change in the federal retirement age enacted in 1983. But a new study shows that today's pre-retirement

By |2017-10-03T15:50:51-04:00October 3rd, 2017|Life Sciences|

Monthly Health Forum Of West Michigan Returns Oct. 6

GRAND RAPIDS - The monthly Health Forum of West Michigan series begins its new year with a panel discussion that focuses on the supply and demand of health care jobs, and how area higher education institutions are working to meet the needs of industry employers and employees. "The Health Care Talent Pipeline" is set for

By |2017-09-28T18:51:21-04:00September 28th, 2017|Life Sciences|

Printed Meds Could Reinvent Pharmacies, Drug Research

ANN ARBOR - A technology that can print pure, ultra-precise doses of drugs onto a wide variety of surfaces could one day enable on-site printing of custom-dosed medications at pharmacies, hospitals and other locations. The technique, which was developed at the University of Michigan, can print multiple medications into a single dose on a dissolvable

By |2017-09-28T10:08:54-04:00September 28th, 2017|Featured, Life Sciences|

Tech248 Member MatchRX Revolutionizing Surplus Prescription Drug Industry

ROYAL OAK - Check out this cool Tech248 member company MatchRX a private web-based inter-pharmacy marketplace to buy and sell small quantities of non-controlled, non-expired overstocked prescription drugs and drugs in short supply to satisfy a specific patient need or declared public health emergency. Tech248 Co-Found Irene Spanos interviews CEO John Kello. MatchRX maintains safe,

By |2017-09-24T18:31:27-04:00September 24th, 2017|Life Sciences, M2 TechCast, Podcasts|

Making Choices Michigan Becomes Wholly Owned Subsidiary of Great Lakes Health Connect

GRAND RAPIDS – Representatives from Great Lakes Health Connect and Making Choices Michigan have announced the integration of their day-to-day operations. MCM will maintain its existing brand and governing board of directors, but will function as a wholly owned subsidiary of GLHC. Doug Dietzman, Executive Director of GLHC, will add leadership responsibility for MCM to

By |2017-09-21T18:59:19-04:00September 21st, 2017|Life Sciences, News|

Labyrinth Chip Could Help Monitor Aggressive Cancer Stem Cells

ANN ARBOR - Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. It is already in use in a breast cancer clinical trial. Tumor cells isolated from blood samples

By |2017-09-21T18:10:37-04:00September 21st, 2017|Life Sciences|